You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

1527 Results
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - In Combination with Carboplatin and Paclitaxel for First-Line Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab,
PACLitaxel,
CARBOplatin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2022
Blog post
In any given year, one in five Canadians will suffer from a mental health problem. For people living with cancer and their families, the risk is...
Aug 2019
Guidelines and Advice
Status: Current
ID: GL 3-20
Version: N/A
Aug 2019
Document
Aug 2019
Document
Aug 2019
Document
Aug 2019
Blog post
Julia A. When Julia A. attended a patient education session about starting chemotherapy, one of the most important pieces of information she received...
Sep 2019
Document
Sep 2019
Document
Sep 2019
Document
Sep 2019

Pages